miércoles, 16 de junio de 2010
Turning a painkiller into a cancer killer: Pain reliever redirected to trigger death pathways in cancer cells
ScienceDaily (2010-06-14) -- Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin have lower incidences of certain types of cancer. Now, in a new study, researchers have figured out how one NSAID, called Sulindac, inhibits tumor growth.http://www.sciencedaily.com/releases/2010/06/100614121608.htm
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario